
Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANIX · as of Jun 8, 2026
Key Statistics
Explore Anixa Biosciences, Inc. Data
anix stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The ANIX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.83, representing +136.99% upside from the current price of $2.46.
Competitors & Peers
anix competitorsStock Performance
Full HistoryAbout Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within…
what is anixa biosciences, inc. · anix stock overview · anixa biosciences, inc. company profile · who is anixa biosciences, inc. ceo · anix NASDAQ · anixa biosciences, inc. headquarters · anixa biosciences, inc. business segments
About Stock Overview & Key Data
Anixa Biosciences, Inc. (ANIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 7, 1983. As of the latest trading session, ANIX stock price is $2.46, with a market capitalization of $82.5M. The stock has returned -27.65% over the past 12 months and -21.15% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Anixa Biosciences, Inc. stock is Buy, with an average 12-month price target of $5.83. In fiscal year 2025, Anixa Biosciences, Inc. reported revenue of — and net income of -$10.9M. For detailed data — including Anixa Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Anixa Biosciences, Inc. (ANIX) stock price is $2.46. The stock is traded on NASDAQ under the ticker symbol ANIX. The 52-week range is $2.44 – $5.46.